Mariangela Gulisano

Dr. Mariangela Gulisano

Department of Clinical and Experimental Medicine, University of Catania
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2010 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
CEC. M. Eddy
C. M. Eddy
RRRenata Rizzo
Renata Rizzo
MGMariangela Gulisano
Mariangela Gulisano
Antonella AgodiAntonella Agodi
Antonella Agodi
Martina BarchittaMartina Barchitta
Martina Barchitta
ACAndrea Cavanna
Andrea Cavanna

10 November 2010 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
CEClare M. Eddy
Clare M. Eddy
ACAndrea E. Cavanna
Andrea E. Cavanna
MGMariangela Gulisano
Mariangela Gulisano
Antonella AgodiAntonella Agodi
Antonella Agodi
Martina BarchittaMartina Barchitta
Martina Barchitta
RRRenata Rizzo
Renata Rizzo

Verified
Journal Article
Open access
PDF file
Maria Alessandra RagusaMaria Alessandra Ragusa
Maria Alessandra Ragusa
MSMaria Santagati
Maria Santagati
FMFederica Mirabella
Federica Mirabella
GLGiovanni Lauretta
Giovanni Lauretta
MCMatilde Cirnigliaro
Matilde Cirnigliaro
MPMichele Purrello
Michele Purrello
Recent evidence has demonstrated that salivary molecules, as well as bacterial populations, can be perturbed by several pathological conditions, including neuro-psychiatric diseases. This relationship between brain functionality and saliva composition could be exploited to unveil new pathological mechanisms of elusive diseases, such as Autistic Spectrum Disorder (ASD). We performed a combined approach of miRNA expression profiling by NanoString technology, followed by validation experiments in qPCR, and 16S rRNA microbiome analysis on saliva from 53 ASD and 27 neurologically unaffected control (NUC) children. MiR-29a-3p and miR-141-3p were upregulated, while miR-16-5p, let-7b-5p, and miR-451a were downregulated in ASD compared to NUCs. Microbiome analysis on the same subjects revealed that Rothia, Filifactor, Actinobacillus, Weeksellaceae, Ralstonia, Pasteurellaceae, and Aggregatibacter increased their abundance in ASD patients, while Tannerella, Moryella and TM7-3 decreased. Variations of both miRNAs and microbes were statistically associated to different neuropsychological scores related to anomalies in social interaction and communication. Among miRNA/bacteria associations, the most relevant was the negative correlation between salivary miR-141-3p expression and Tannerella abundance. MiRNA and microbiome dysregulations found in the saliva of ASD children are potentially associated with cognitive impairments of the subjects. Furthermore, a potential cross-talking between circulating miRNAs and resident bacteria could occur in saliva of ASD.

1 September 2012 in Brain and Development
Verified
Journal Article
Closed access
RRRenata Rizzo
Renata Rizzo
MGMariangela Gulisano
Mariangela Gulisano
PCPaola Valeria Calì
Paola Valeria Calì
PCPaolo Curatolo
Paolo Curatolo

1 October 2012 in The Journal of Neuropsychiatry and Clinical Neurosciences
Verified
Journal Article
Closed access
PDF file
CEClare M. Eddy
Clare M. Eddy
ACAndrea Cavanna
Andrea Cavanna
MGMariangela Gulisano
Mariangela Gulisano
PCPaola Calì
Paola Calì
MRMary M. Robertson
Mary M. Robertson
RRRenata Rizzo
Renata Rizzo

1 August 2007 in Brain and Development
Verified
Journal Article
Closed access
RRRenata Rizzo
Renata Rizzo
PCPaolo Curatolo
Paolo Curatolo
MGMariangela Gulisano
Mariangela Gulisano
MVMarina Virzì
Marina Virzì
CACarla Arpino
Carla Arpino
MRMary M. Robertson
Mary M. Robertson